Using chimeric recombinants transfected into HeLa cells and a transient expression assay, we demonstrate that the 5'-flanking region of the pS2 gene from position -428 to position -324 exhibits both constitutive and estrogeninducible enhancer activity. The estrogen-inducible activity, but not the constitutive activity, was inhibited by antiestrogens.
activity are spread over the entire region.
The human pS2 gene was initially characterized as a gene whose expression is specifically controlled by estrogen in the breast cancer cell line MCF-7 (1, 2) . The increase in pS2 mRNA after addition of estradiol to the culture medium is a primary transcriptional event (3) , suggesting that control of pS2 gene promoter activity by the estrogen receptor is mediated by a cis-acting estrogen-responsive element (ERE) that could be located in the 5'-flanking region ofthe pS2 gene. Using MCF-7 cells transformed with chimeric recombinants containing the promoter region of the pS2 gene controlling transcription of the gene conferring resistance to neomycin (G418), it has indeed been shown that the 5'-flanking region of the pS2 gene from position approximately -3000 to position +10 contains an estrogen-responsive promoter (4) . The Expression from pS2( -3000/+10)CAT, pS2(=" -1100/ +10)CAT, or pS2(-428/+10)CAT, where the ends of the inserted pS2 sequences are given in parentheses, could be stimulated by addition of estradiol, whereas pS2(-90/+10)-CAT was not inducible by estradiol, suggesting the presence of an ERE within the flanking sequence from position -428 to position -90 (ref. 6 and M.B., unpublished results). To investigate whether this ERE may correspond to an inducible-enhancer element, we next constructed a series of chimeric recombinants in which the 5'-flanking sequence from position approximately -3500 to position -87, from approximately -1100 to -86, from -428 to -87, and from -332 to -87 were fused in either orientation to the heterologous rabbit 8-globin gene truncated at position -109.
Transfection of these recombinants together with the human estrogen receptor expression vector HEO in the presence or absence of estradiol led to the hypothesis that both constitutive and estrogen-inducible enhancer elements are located within the region of the pS2 gene from position -428 to position -332 (7) .
In the present study we demonstrate that the pS2 gene sequence from position -428 to position -324 indeed contains both constitutive and estrogen-inducible enhancer elements. Furthermore, the exact location of the ERE has been determined by using both deletion and point mutagenesis. We show that the pS2 ERE sequence is related to those of characterized EREs but that it is not a perfect palindrome, which results in a weaker ERE. 
MATERIALS AND METHODS
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The activation vector HEO expressing the human estrogen receptor was as described (5) .
HeLa Cell Transfection and Quantitative S1 Nuclease Analysis. HeLa cells were grown as described (6) in the presence of dextran-coated charcoal-treated fetal calf serum (stripped serum) (12) and in the absence of phenol red (13) . All transfections were carried out by the calcium phosphate coprecipitate technique (14) . Estradiol and anti-estrogens were added 2 hr after transfection. RNA isolation and analysis by quantitative S1 nuclease mapping using singlestranded 5'-end-labeled probes were performed as described (6) . The pS2 probe was constructed by inserting the BamHIBamHI fragment of the pS2 recombinant described by Kumar et al. (6) (pS2 fragment from position -91 to position +10 linked to the p-globin gene fragment from position -9 to position +396) into the BamHI site of M13mpl8. The preparation of the antisense single-stranded probe 32P-labeled on the 5' end has been described (6) . The probe covers the M13mpl8 polylinker from the EcoRI site, the pS2 region (between positions -91 and + 10), and the P-globin sequence (between positions -9 and +60). Transcription initiated at the 8-globin start site protects a 60-base-pair fragment (pG1 and pG2 derived recombinants). Transcription starting at the simian virus 40 promoter [pAO (15) , used as an internal reference plasmid] protects all of the globin part of the probe (69 base pairs). Autoradiograms from several independent experiments similar to those shown in the figures were scanned using a densitometer and the data were corrected for variations in transfection efficiencies by taking into account the signals given by the co-transfected reference plasmid pAO (see ref. 6 ).
RESULTS
The 5'-Flanking Region of the pS2 Gene Between Positions -428 and -324 Contains Both Constitutive and EstrogenInducible Enhancer Activities. We have shown elsewhere that the 5'-flanking region of the pS2 gene between positions -428 and -87 contains both constitutive and estrogen-inducible enhancer activities capable of stimulating transcription from the heterologous rabbit f3-globin gene promoter truncated at position -109 (pG1 recombinant) (ref. 7 and Fig. 1A) . A series of additional reporter genes were constructed to further delineate the pS2 gene 5'-flanking sequences responsible for these activities (see Fig. 1A ). These reporter genes were transfected into HeLa cells together with the estrogen receptor expression vector HEO (5) and a reference recombinant pAO (15) to normalize the results for possible variations in transfection efficiency. The enhancing effect of the pS2 gene 5'-flanking sequence was measured by quantitative S1 nuclease analysis of RNA initiated from the P-globin gene promoter of pG1 (+ 1 globin signal in figures). RNA initiated from the cotransfected reference gene pAO that contains the simian virus 40 early promoter region located upstream from the rabbit ,B-globin gene sequence truncated at position -9 was measured with the same S1 nuclease probe (-9 globin signal in figures). The autoradiograms shown in the figures are typical of several similar transfection experiments that, in each case, were carried out with at least two different plasmid-DNA preparations. Transcription initiated at the globin cap site (+ 1 globin) was quantitated by densitometry of appropriately exposed autoradiograms and, after correction for transcription from the reference plasmid pAO, expressed as fold stimulation relative to transcription from the parental recombinant pG1.
In agreement with results published elsewhere (7), transcription from the pG1 globin promoter of pS2(429/86)pGl was stimulated -20-fold and 190-fold in the absence and in the presence of estradiol, respectively, whereas no or very quantitative S1 nuclease analysis, as described in Fig. 1 Fig. 1 with pS2BpG1 in Fig. 3 ]. On the other hand, the constitutive enhancer activity appears to be scattered throughout the region between positions -419 and -322, since four deletions (A, D, E, and F) clearly adversely affected this activity (Fig. 3 ). Fig. 1 . The loss of estrogen inducibility in the mutant bearing deletion B prompted us to look in the sequence of the corresponding region for a motif similar to the consensus ERE (17) . No such sequence was present in the previously reported (18) pS2 gene 5'-flanking sequence. However, we found that this published sequence contains a number of mistakes that occurred when it was entered in the computer. The corrected pS2 gene sequence from position -430 to position -320 is displayed in Fig. 4 . When comparing this sequence with that of the consensus palindromic ERE (5'-GGTCANNNTGACC-3', see ref. 17) , it was apparent that a closely related sequence (between positions -405 and -393, 5'-GGTCACGGTGGCC-3') was overlapping with deletion B, the only difference being an adenosine to guanosine transition in the 3' stem of the palindrome.
The Isolated Imperfect Palindromic Sequence from Position -405 to Position -393 Is an ERE. The imperfectly palindromic putative ERE sequence of the pS2 gene was chemically synthesized and inserted upstream to the /3-globin gene promoter in either pG1 (pS2-EREpG1) or pG2 (pS2-EREpG2) (Fig. 5A) . Its ability to mediate estrogen induction was compared with that of the perfectly palindromic consen- Fig. 5A ). The results of quantitative S1 nuclease analysis of several transfection experiments similar to those present in Fig. 5B were averaged and are presented in Fig. 5A (numbers are given in parentheses) as fold stimulation of transcription by the estrogen receptor upon addition of estradiol to the culture medium ofthe transfected HeLa cells.
The imperfectly palindromic pS2 sequence is acting as an ERE, albeit with a stimulatory activity lower than that of the perfectly palindromic ERE (Fig. 5 ). This lower efficiency was particularly noticeable when the EREs were inserted in pG2 at position -425 with respect to the globin cap site (i.e., at a position corresponding to the natural position of the pS2 ERE). The requirement for a palindromic sequence to achieve maximal estrogen stimulation was further supported by introducing additional point mutations in the 3' stem ofthe pS2 ERE (pS2-EREM1pG1 and pS2-EREM2pG1 in Fig. 5 ).
Finally, we note that the estrogen stimulation (-4. Fig. 4 ). (20, 22, 23) . This indicates clearly that not all of the bases of the palindrome (see also Fig. 5 , pS2-EREM1 and pS2-EREM2) are equally important for estrogen responsiveness-i.e., estrogen receptor binding (21) . Moreover, at a given position within the palindrome, the nature of the base that deviates from the consensus sequence is also important, since the presence of a thymidine instead of a guanosine at the deviating position of the pS2 ERE generates an inactive ERE (22) . Deletions of sequences located upstream (deletion A in Fig. 4 ) and downstream (deletion C in Fig. 4 ) from the pS2 ERE (deletion B in Fig. 4 
